Taro Corporate
Taro U.S.A
Taro Canada
Taro Israel
Sun Pharma
Chattem Chemicals Inc.
Taro RX product details
Product Information
-
DIN:02547635
-
Active Ingredients :palbociclib
-
Innovator Name:Ibrance®
-
Category:Protein Kinase Inhibitor
-
Dosage form:Immediate-Release Tablets
-
Strength:75 mg
-
Route of Administration:Oral
- Package size:
3 weekly blister packs of 7 tablets each (21 tablets total) - UPC Code:
063691101944 -
Non-medicinal ingredients :Anhydrous citric acid, colloidal silicon dioxide, crospovidone, magnesium stearate, microcrystalline cellulose, sodium stearyl fumarate, succinic acid. Film coating material: 75 mg tablets: FD&C blue #2, hypromellose, iron oxide red, titanium dioxide, and triacetin.
All brand names and trademarks referenced remain the property of their respective owners.
To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.
For Provincial Formulary Status click here
Product Information
-
DIN:02547643
-
Active Ingredients :palbociclib
-
Innovator Name:Ibrance®
-
Category:Protein Kinase Inhibitor
-
Dosage form:Immediate-Release Tablets
-
Strength:100 mg
-
Route of Administration:Oral
- Package size:
3 weekly blister packs of 7 tablets each (21 tablets total) - UPC Code:
063691101968 -
Non-medicinal ingredients :Anhydrous citric acid, colloidal silicon dioxide, crospovidone, magnesium stearate, microcrystalline cellulose, sodium stearyl fumarate, succinic acid. Film coating material: 100 mg tablets: FD&C blue #2, hypromellose, iron oxide yellow, titanium dioxide, and triacetin.
All brand names and trademarks referenced remain the property of their respective owners.
To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.
For Provincial Formulary Status click here
Product Information
-
DIN:02547651
-
Active Ingredients :palbociclib
-
Innovator Name:Ibrance®
-
Category:Protein Kinase Inhibitor
-
Dosage form:Immediate-Release Tablets
-
Strength:125 mg
-
Route of Administration:Oral
- Package size:
3 weekly blister packs of 7 tablets each (21 tablets total) - UPC Code:
063691101982 -
Non-medicinal ingredients :Anhydrous citric acid, colloidal silicon dioxide, crospovidone, magnesium stearate, microcrystalline cellulose, sodium stearyl fumarate, succinic acid. Film coating material:125 mg tablets: FD&C blue #2, hypromellose, iron oxide red, titanium dioxide, and triacetin.
All brand names and trademarks referenced remain the property of their respective owners.
To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.
For Provincial Formulary Status click here